A comparison of clinical outcomes between healthcare-associated infections due to community-associated methicillin-resistant Staphylococcus aureus strains and healthcare-associated methicillin-resistant S. aureus strains

Epidemiology and Infection

Volumn 141, Issue 10, 2013, Pages 2140-2148

  Eells, S J ^a,b   Mckinnell, J A ^a,b   Wang, A A ^a   Green, N L ^c   Whang, D ^c   O'Hara, P ^d   Brown, M L ^d   Miller, L G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Community associated; genotype; healthcare associated; MRSA; outcomes

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; LINEZOLID; MINOCYCLINE; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; APACHE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; REVIEW; RISK FACTOR; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; GENOTYPE; HEALTH STATUS INDICATORS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84883347944     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812002634     Document Type: Review

References (39)

1. Hidron AI, et al. NHSN annual update: Antimicrobialresistant pathogens associated with healthcareassociated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection Control and Hospital Epidemiology 2008; 29: 996-1011
2. McDougal LK, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: Establishing a national database. Journal of Clinical Microbiology 2003; 41: 5113-5120
3. Seybold U, et al. Emergence of community-Associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-Associated blood stream infections. Clinical Infectious Diseases 2006; 42: 647-656
4. Maree C, et al. Community-Associated methicillinresistant Staphylococcus aureus strains causing healthcare-Associated infections. Emerging Infectious Diseases 2007; 13: 236-242
5. Rodriguez-Bano J, et al. Clinical and molecular epidemiology of community-Acquired, healthcare-Associated and nosocomial methicillin-resistant Staphylococcus aureus in Spain. Clinical Microbioliology and Infection 2009; 15: 1111-1118
6. Gonzalez BE, et al. Community-Associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-Associated infection. Infection Control and Hospital Epidemiology 2006; 27: 1051-1056
7. Klevens RM, et al. Community-Associated methicillinresistant Staphylococcus aureus and healthcare risk factors. Emerging Infectious Diseases 2006; 12: 1991-1993
8. Stranden AM, et al. Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital. Infection 2009; 37: 44-48
9. Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128-1132
10. Okuma K, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. Journal of Clinical Microbiology 2002; 40: 4289-4294
11. Moran GJ, et al. Methicillin-resistant Staphylococcus aureus in community-Acquired skin infections. Emerging Infectious Diseases 2005; 11: 928-930
12. Voyich JM, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-Associated methicillin-resistant Staphylococcus aureus disease ? Journal of Infectious Diseases 2006; 194: 1761-1770
13. Labandeira-Rey M, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315: 1130-1133
14. Davis SL, et al. Characteristics of patients with healthcare-Associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology 2006; 27: 1025-1031
15. Wang JT, et al. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: With investigation of the potential role of community-Associated MRSA strains. Journal of Infection 2010; 61: 449-457
16. Kreisel KM, et al. USA300 methicillin-resistant Staphylococcus aureus bacteremia and the risk of severe sepsis: Is USA300 methicillin-resistant Staphylococcus aureus associated with more severe infections ? Diagnostic Microbiology and Infectious Disease 2011; 70: 285-290
17. Ganga R, et al. Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center. Journal of Clinical Microbiology 2009; 47: 590-595
18. Kempker RR, et al. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. Journal of Infection 2010; 61: 372-381
19. Hota B, et al. Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: The importance of USA300 and pneumonia. Clinical Infectious Diseases 2011; 53: 757-765
20. Moore CL, et al. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community-And healthcare-Associated infections. International Journal of Antimicrobial Agents 2009; 34: 148-155
21. Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 1763-1771
22. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-Associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control 2008; 36: 309-332
23. Wenzel RP. Perspective: Attributable mortality-The promise of better antimicrobial therapy. Journal of Infectious Diseases 1998; 178: 917-919
24. Miller LG, et al. Clinical and epidemiologic characteristics cannot distinguish community-Associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: A prospective investigation. Clinical Infectious Diseases 2007; 44: 471-482
25. Miller LG, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-Acquired methicillin-resistant and-susceptible Staphylococcus aureus skin infection. Clinical Infectious Diseases 2007; 44: 483-492
26. Yang ES, et al. Body site colonization in patients with community-Associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clinical Microbiology and Infection 2010; 16: 425-431
27. Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases 1987; 40: 373-383
28. Knaus WA, et al. APACHE II: A severity of disease classification system. Critical Care Medicine 1985; 13: 818-829
29. Mellmann A, et al. Based upon repeat pattern (BURP): An algorithm to characterize the long-Term evolution of Staphylococcus aureus populations based on spa polymorphisms. BMC Microbiology 2007; 7: 98
30. Enright MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillinsusceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008-1015
31. Goering RV, et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. Journal of Clinical Microbiology 2008; 46: 2842-2847
32. Brown ML, et al. Prevalence and sequence variation of Panton-Valentine leukocidin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the United States. Journal of Clinical Microbiology 2012; 50: 86-90
33. Kleinbaum DG, Klein M, Pryor ER. Logistic Regression: A Self-learning Text. (Statistics for Biology and Health). Ebooks Corp., 2002
34. Robinson JO, et al. Community-Associated versus healthcare-Associated methicillin-resistant Staphylococcus aureus bacteraemia: A 10-year retrospective review. European Journal of Clinical Microbiology & Infectious Diseases 2009; 28: 353-361
35. Lin CC, et al. Methicillin-resistant Staphylococcus aureus bacteremia in patients with end-stage renal disease in Taiwan: Distinguishing between communityassociated and healthcare-Associated strains. Infection Control and Hospital Epidemiology 2009; 30: 89-92
36. Park SH, et al. Emergence of community-Associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-Associated bloodstream infections in Korea. Infection Control and Hospital Epidemiology 2009; 30: 146-155
37. Roberts MC, et al. Characterization of methicillinresistant Staphylococcus aureus isolated from public surfaces on a university campus, student homes and local community. Journal of Applied Microbiology 2011; 110: 1531-1537
38. Diep BA, et al. Emergence of multidrug-resistant, community-Associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Annals of Internal Medicine 2008; 148: 249-257
39. Han LL, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. Journal of Clinical Microbiology 2007; 45: 1350-1352